SEC Form 3/A · accession 0001441557-16-000099
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. · CELZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
Thomas Ichim
Director
Period of report
May 18, 2016
Accepted (ET)
Oct 24, 2016 · 11:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001187953
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | holding | — | — | — | 2,586,667 | I | LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The number of shares previously reported in the original Form 3 did not reflect the exchange rate for the shares issued in the reverse acquisition transaction which required the filing of the report.
- F2Shares are held by BioTech Holdings, LLC, of which Dr. Ichim is President. Dr. Ichim disclaims beneficial ownership of such shares of common stock except to the extent of his pecuniary interest therein.